aminocaproic acid has been researched along with Cell Transformation, Neoplastic in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durkan, K | 1 |
| Jiang, Z | 1 |
| Rold, TL | 1 |
| Sieckman, GL | 1 |
| Hoffman, TJ | 1 |
| Bandari, RP | 1 |
| Szczodroski, AF | 1 |
| Liu, L | 1 |
| Miao, Y | 1 |
| Reynolds, TS | 1 |
| Smith, CJ | 1 |
| Tolmachev, V | 1 |
| Feldwisch, J | 1 |
| Lindborg, M | 1 |
| Baastrup, B | 1 |
| Sandström, M | 1 |
| Orlova, A | 1 |
2 other studies available for aminocaproic acid and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
Topics: Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; | 2014 |
Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate.
Topics: Amino Acid Sequence; Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; | 2011 |